Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients with Hereditary Angioedema,Pharvaris Netherlands B.V.,Interventional,Phase 2/Phase 3
The PHA022121-C303 app is intended to collect patient reported outcomes for the PHA022121-C303 clinical study. Your study site will provide you with a QR code t…